Fresenius Medical Care Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Fresenius Medical Care Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 1, 2024	Memo Therapeutics	$22.0M Series C	—	Kurma Partners, Adjuvant Capital, GF Group, Pureos Bioventures, Redalpine, Schroders Capital, Swisscanto Invest, Verve Ventures, Vesalius Biocapital, Thomas Harth
Nov 1, 2023	Memo Therapeutics	$28.0M Series C	Veronica Gambillara Fonck	Adjuvant Capital, Kurma Partners, Pureos Bioventures, GF Group, Redalpine, Schroders Capital, Swisscanto Invest, Verve Ventures, Vesalius Biocapital
Jul 18, 2022	Retia Medical	$15.0M Series B	Al Wiegman	Priztker/Vlock Family Office, Red Cedar Ventures
Feb 1, 2022	Memo Therapeutics	$25.0M Series B	Swisscanto Invest, Swiss Federal Office of Public Health	Adjuvant Capital, Kurma Partners, Pureos Bioventures, Andreas Wüpper, GF Group, Verve Ventures, Christian Schneider, Zürcher Kantonalbank
Nov 1, 2019	EGenesis	$100.0M Series B	Al Wiegman	ARCH Venture Partners, Biomatics Capital Partners, Leaps by Bayer, Lux Capital, Menlo Ventures, Isaac Ciechanover
Jan 1, 2019	Modulim	$7.0M Series B	Pangaea Ventures	Fouse, Al Wiegman, Grey Sky Venture Partners, Mitsubishi UFJ Capital
Dec 18, 2018	Tridiuum	$9.5M Series B	Mark Groner	Ben Franklin Technology Partners of Southeastern Pennsylvania, Al Wiegman, Martinson Ventures
Apr 25, 2018	Corvidia	$60.0M Series B	Karim Helmy	Andera Partners, Apple Tree Partners, Cormorant Asset Management, HBM Healthcare Investments, MedImmune, Sofinnova Partners
Nov 16, 2017	Modulim	$4.1M Grant / Series A	Grey Sky Venture Partners	Mitsuharu Miwa, Mitsubishi UFJ Capital, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Jun 2, 2016	ExThera Medical	$15.3M Series B	Olaf Schermeier	—